entertainment -WSS

entertainment

author：knowledge 2025-09-14 11:50:57 - browse：763

Medicare generally pays far more for CAR-T drugs that are administered in outpatient departments than it does for inpatient care. Adobe

WASHINGTON — Hospitals for years have complained that Medicare pays so little for CAR-T cancer treatments that they sometimes lose money administering the incredibly expensive treatments. But that could soon change: if drug companies succeed in making the cancer treatments safer, hospitals could provide them more often in outpatient departments, where payment is higher.

CAR-T uses the body’s own immune system to kill cancerous cells. The procedure, regulated as a drug, involves taking T cells from a patient’s blood, adding chimeric antigen receptors (CAR) to the T cells that kill cancer, and injecting the CAR-T treatment back into the patient.

It’s worked wonders in many cancer patients who have run out of options. But right now it’s almost exclusively administered in hospitals, because the side effects can require aggressive treatments. In many cases, the CAR-T cells trigger immune reactions that can be life-threatening.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Cancer diagnosis changes perspective doctor, former hospital CEO

WSS

National associations that represent hospice owe an apology

What health policies could hitch a ride on a spending bill?

Hospital at home shows how to bring innovation to health care

Roche's accidental data boosts hopes for anti

Trans patients at the end of life deserve respect and dignity

National associations that represent hospice owe an apology

hotspot

entertainment

hotspot

Apple is now the first public company to be valued at $3 trillion

Trans patients at the end of life deserve respect and dignity

How to save PrEP access — and even expand it

Can U.S. cancer drug shortages be fixed?

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

DeSantis wants to import drugs. Biden’s FDA blasted his plan

Jerome Adams on the need for new antivirals for Covid

Publishing genetic code of viruses could cause disaster

Cancer drug shortages should be causing more outrage

PBMs are inflating the cost of generic drugs. They must be reined in

knowledge

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

NIH chief: government has fallen behind pharma on clinical trials

How to make over

Ventyx halts psoriasis drug development after lackluster trial results

CDC says it’s too soon to assess risk posed by Covid subvariant

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

Wikipedia

leisure time

hotspot

focus